secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001104659-25-120915
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte terminates Revenue Interest Purchase Agreement; pays $38M cash + 5.7M shares to purchasers
--------------------------------------------------------------------------------

- Terminated Revenue Interest Purchase Agreement and Option Agreement with TPC Investments LP and Hook SA LLC as of Dec 15, 2025.
- Consideration: $38 million cash (funded via new credit facility) plus 5,725,190 shares of common stock in a registered direct offering.
- Offering closes Dec 15, 2025; shares issued under effective shelf registration statement (File No. 333-290231).
- Company expects to fund $38M cash payment from proceeds of a new credit facility.
- Satisfaction of all obligations under terminated agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925120915/0001104659-25-120915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925120915/tm2533185d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-120915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer